CUSIP 171757206COM NEWCDTXQ4 2025
42 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 3.37M | $743.41M |
| 2 | Vanguard Group Inc | 2.01M | $443.37M |
| 3 | Blackrock, Inc. | 1.68M | $371.24M |
| 4 | Hbk Investments L P | 1.26M | $278.32M |
| 5 | Fil Ltd | 1.26M | $277.79M |
| 6 | Ubs Group AG | 1.07M | $237.44M |
| 7 | Darwin Global Management, Ltd. | 997.2K | $220.18M |
| 8 | Vivo Capital, LLC | 956.7K | $211.32M |
| 9 | State Street Corp |
| 4 | Jan 30, 2026 | The Vanguard Group | 13G | 6.4% | 2.01M | SEC |
| 5 | Jan 9, 2026 | Ra Capital Management, L.P. | 13D/A | — | — | SEC |
| 6 | Nov 17, 2025 | Ra Capital Management, L.P. | 13D/A | 10.7% | — | SEC |
| 7 | Nov 14, 2025 | Commodore Capital LP | 13G/A | 11.0% | 585.0K | SEC |
| 8 | Nov 14, 2025 | Bcls Fund III Investments, LP | 13G/A | 10.0% | 3.02M | SEC |
| 9 | Nov 14, 2025 | Tcg Crossover Gp II, LLC | 13G/A | 11.0% | 9 | SEC |
| 10 | Nov 14, 2025 | Paradigm Biocapital Advisors LP | 13G/A | 3.3% | 9.23B | SEC |
See the full Schedule 13D/13G history for Cidara Therapeutics Inc.
Unlock full history| 884.4K |
| $195.35M |
| 10 | Jefferies Financial Group Inc. | 766.5K | $169.32M |